Items Tagged ‘chemotherapy’
January 27, 2020
Neuro regeneration for chemo brain: Mi-Hyeon Jang, Ph.D.
Cognitive dysfunction, sometimes called “chemo brain,” stemming from chemotherapy is a major adverse condition affecting approximately 14 million cancer patients and survivors in the United States. Although chemo brain has been widely reported by patients and clinicians, the cause of concentration and memory problems in cancer patients is not well understood. Mayo Clinic researchers are […]
Tags: cancer, Center for Regenerative Medicine, chemo brain, chemotherapy, Mayo Clinic Cancer Center, Mi-Hyeon Jang, neuroregeneration, regenerative medicine, Regenerative Medicine Minnesota, stem cells
January 7, 2020
Research News Roundup–December 2019
December’s Research News Roundup highlights a number of advancements in understanding and treating different cancers, including blood, breast and gastrointestinal; in addition to other research news from Mayo Clinic. The Roundup also connects readers to related resources. Read on for more information from Mayo Clinic Research. Study finds less-aggressive chemotherapy after initial treatment for metastatic colorectal […]
Tags: breast cancer, cancer, cancer genomics, CAR-T, cardiovascular medicine, chemotherapy, chronic lymphocytic leukemia, colorectal cancer, endometrial cancer, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center
October 14, 2019
BEAUTY Update: Progress in breast cancer research
By Advancing the Science contributor 
By Barbara J. Toman Chemotherapy is a standard breast cancer treatment, used for aggressive biology breast cancer to shrink tumors in the breast and lymph nodes before surgery, assess response and destroy any undetected cancer cells elsewhere in the patient. But some breast tumors don’t respond well to chemotherapy, putting patients at high risk of […]
Tags: breast cancer, cancer, Center for Individualized Medicine, chemotherapy, clinical trials, genetics, genomics, individualized medicine, Judy Boughey, Liewei Wang, Matthew Goetz, Mayo Clinic Cancer Center
October 4, 2019
Chemo first for better outcomes in bile duct cancer, says new research
Oncology care teams frequently use chemotherapy along with surgery to treat cholangiocarcinoma, or bile duct cancer. However, until now, little evidence existed regarding if and when receiving chemotherapy was likely to have the best effect. Recently Mayo Clinic researchers found that patients who received chemotherapy before surgery to remove their bile duct cancer were more […]
Tags: Amit Mahipal, bile ducts, cancer, Center for the Science of Health Care Delivery, chemotherapy, cholangiocarcinoma, gastrointestinal cancer, hematology, Mayo Clinic Cancer Center, oncology, rare disease, Siddhartha Yadav
October 2, 2019
Research News Roundup–September 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research-related news releases from Mayo Clinic in the past month. It also connects readers to associated resources. Read on for more information from Mayo Clinic Research. Medications underused in treating opioid addiction, Mayo Clinic expert says Though research shows that medication-assisted treatment can help […]
Tags: aging, artificial intelligence, ASTRO, basic science, brain tumor, cancer, cardiology, Center for the Science of Health Care Delivery, chemotherapy, clinical trials, collaboration, coronary bypass
September 27, 2019
Read the Latest Research News from Mayo Clinic Cancer Center
Forefront is the complimentary magazine of the Mayo Clinic Cancer Center. Published in email and online newsletter editions quarterly, Forefront highlights Mayo Clinic’s cutting-edge cancer research and the latest Cancer Center news. The September 2019 issue features: Director’s message: Recognition for a job well doneAfter a rigorous review, NCI has renewed Mayo Clinic Cancer Center’s […]
Tags: Barrett's esophagus, breast cancer, chemotherapy, Donald Northfelt, Forefront, Mayo Clinic Cancer Center, myeloma, National Cancer Institute, pancreatic cancer
September 3, 2019
Research News Roundup–August 2019
Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Genetically manipulating protein level in colon cancer cells can […]
Tags: Alan Fields, artificial intelligence, atrial fibrillation, basic science, cardiology, cardiovascular disease, chemotherapy, Colin West, colorectal cancer, diabetes, Frank Sinicrope, Lotte Dyrbye
October 11, 2018
Nausea and vomiting: Not just a possible symptom, a dreaded reality for some
Michelle was the matriarch of a big Italian family. Her life revolved around taking care of others and her love language was food. When she was diagnosed with stage IV breast cancer, her life and family activities suddenly screeched to a halt. Her oncologist and health care team acted quickly and put her on chemotherapy, […]
Tags: Aminah Jatoi, cancer, Center for the Science of Health Care Delivery, chemotherapy, Mayo Clinic Cancer Center
June 28, 2017
Underused cancer test could improve treatment for thousands, Mayo Clinic study finds
With colon cancer, some earlier stage patients fare worse than some later stage patients, who usually benefit most from chemotherapy. But a research team at Mayo Clinic has discovered that a simple blood test could help determine which patients are at a higher risk and therefore could benefit from therapy. The researchers also found many patients who could benefit from the test likely aren’t receiving it.
Tags: cancer, Center for the Science of Health Care Delivery, chemotherapy, colon cancer, Kellie Mathis, Mayo Clinic School of Graduate Medical Education
December 29, 2016
Drug combo stems tumor growth in lung cancer
Researchers on Mayo Clinic’s campus in Jacksonville, Florida, have shut down one of the most common and lethal forms of lung cancer by combining the rheumatoid arthritis drug auranofin with an experimental targeted agent. The combination therapy worked in a laboratory study to stop lung adenocarcinoma associated with mutation of the KRAS gene. The study […]
Tags: chemotherapy, Forefront, lung cancer